AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H2654-H2663, 2007. First published February 2, 2007; doi:10.1152/ajpheart.01255.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/6/H2654    most recent
01255.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luykenaar, K. D.
Right arrow Articles by Welsh, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luykenaar, K. D.
Right arrow Articles by Welsh, D. G.

Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries

Kevin D. Luykenaar and Donald G. Welsh

Department of Physiology and Biophysics, University of Calgary, Alberta, Canada

Submitted 16 November 2006 ; accepted in final form 30 January 2007

This study tested whether activation of protein kinase A (PKA) and G (PKG) pathways would attenuate the ability of RhoA to suppress the delayed rectifier K+ (KDR) current and limit agonist-induced depolarization and constriction. Smooth muscle cells from rat cerebral arteries were enzymatically isolated, and whole cell KDR currents were monitored with conventional patch-clamp electrophysiology. The KDR current averaged 21.2 ± 2.3 pA/pF (mean ± SE) at +40 mV and was potently inhibited by UTP. Current suppression was eliminated in the presence of C3 exoenzyme, confirming that this modulation is dependent on RhoA. Activation of PKA (dibutyryl-cAMP, forskolin) or PKG (dibutyryl-cGMP, sodium nitroprusside, nitric oxide) similarly abolished the ability of UTP to suppress KDR and did so without effect on baseline current. Using pressure myography techniques, we stripped cerebral arteries of endothelium and preconstricted them with UTP; these were subsequently shown to hyperpolarize and dilate to both forskolin and sodium nitroprusside. An increase in KV channel activity was found to partly underlie these associated changes, as constriction to 4-aminopyridine (KDR channel blocker) was greater after PKA or PKG activation. We conclude from our electrophysiological and functional observations that the PKA and PKG pathways attenuate the ability of UTP to depolarize and constrict cerebral arteries in part by minimizing the RhoA-mediated suppression of the KDR current.

cyclic nucleotides; pyrimidine nucleotides; Rho signaling; smooth muscle



Address for reprint requests and other correspondence: D. G. Welsh, Smooth Muscle Research Group, HMRB-G86, Heritage Medical Research Bldg., Univ. of Calgary, 3330 Hospital Dr. N.W., Calgary, Alberta, Canada, T2N-4N1 (e-mail: dwelsh{at}ucalgary.ca)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Luykenaar, R. A. El-Rahman, M. P. Walsh, and D. G. Welsh
Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H917 - H926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L.-M. Jin
Rock 'n' Rho: regulation of ion channels
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H908 - H909.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.